From atopic dermatitis to asthma what drives the allergic march? Source: Eur Respir J 2003; 22: Suppl. 45, 137s Year: 2003
The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: 330 Year: 2004
Controlled asthma in atopic and non atopic patients: Is needed a different approach? Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011
Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The relation between atopic and non-atopic asthma and PPD response Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Additional clinical parameters for atopic and nonatopic asthma differences in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 400s Year: 2005
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Source: Eur Respir J 2001; 18: 254-261 Year: 2001
Timing of solid food introduction in relation to atopic eczema and atopic sensitisation Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005
The effects of anti-IL-13 on allergen-induced responses; a Phase II study in subjects with mild atopic asthma - The allergen challenge as a model of allergic asthma for proof-of-concept studies Source: Annual Congress 2008 - Clinical trial - The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen-induced airway responses in subjects with mild atopic asthma Year: 2008
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Does allergens influence resistin levels in children with allergic rhinitis? Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Asthma and allergic rhinitis - clinical presentation of effects different types of drugs Source: Eur Respir J 2005; 26: Suppl. 49, 506s Year: 2005
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2002; 20: 73-78 Year: 2002
Is montelukast effective in allergic rhinitis in children? Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006
Allergen-specific IgE patterns in allergic diseases of respiratory system with atopic dermatitis. Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Specific allergen immunotherapy of asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006